{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:00:31Z","timestamp":1772164831583,"version":"3.50.1"},"reference-count":24,"publisher":"American Association for Cancer Research (AACR)","issue":"3","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["TL1TR000369"],"award-info":[{"award-number":["TL1TR000369"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lack of robust activation of Stimulator of Interferon Genes (STING) pathway and subsequent induction of type I IFN responses is considered a barrier to antitumor immunity in acute myeloid leukemia (AML). Using common human AML cell lines as in vitro tools to evaluate the efficacy of novel STING agonists, we found most AML lines to be poor producers of IFNs upon exposure to extremely potent agonists, suggesting cell-intrinsic suppression of STING signaling may occur. We observed unexpected patterns of response that did not correlate with levels of STING pathway components or of known enzymes associated with resistance. To identify a genetic basis for these observations, we cloned and sequenced STING from the cDNA of human AML cell lines and found both frequent mutations and deviations from normal RNA splicing. We identified two novel spliced isoforms of STING in these lines and validated their expression in primary human AML samples. When transduced into reporter cells, these novel STING isoforms exhibited complete insensitivity to agonist stimulation. These observations identify alternative splicing as a mechanism of STING pathway suppression and suggest that most AML silences the STING pathway through direct modification rather than through engagement of external inhibitory factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We find that AML acquires resistance to innate immune activation via the STING pathway through aberrant splicing of the STING transcript including two novel forms described herein that act as dominant negatives. These data broaden understanding of how cancers evolve STING resistance, and suggest that the AML tumor microenvironment, not the cancer cell, should be the target of therapeutic interventions to activate STING.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0095","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:56:46Z","timestamp":1710320206000},"page":"911-918","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-0498","authenticated-orcid":true,"given":"Akash R.","family":"Boda","sequence":"first","affiliation":[{"name":"1Immunology Program, The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas."},{"name":"2Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-9209","authenticated-orcid":true,"given":"Arthur J.","family":"Liu","sequence":"additional","affiliation":[{"name":"1Immunology Program, The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas."},{"name":"2Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-1560","authenticated-orcid":true,"given":"Susana","family":"Castro-Pando","sequence":"additional","affiliation":[{"name":"1Immunology Program, The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas."},{"name":"3Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-8464","authenticated-orcid":true,"given":"Benjamin T.","family":"Whitfield","sequence":"additional","affiliation":[{"name":"1Immunology Program, The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-1715","authenticated-orcid":true,"given":"Jeffrey J.","family":"Molldrem","sequence":"additional","affiliation":[{"name":"4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7648-4377","authenticated-orcid":true,"given":"Gheath","family":"Al-Atrash","sequence":"additional","affiliation":[{"name":"4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5132-1643","authenticated-orcid":true,"given":"Maria Emilia","family":"Di Francesco","sequence":"additional","affiliation":[{"name":"5Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-8293","authenticated-orcid":true,"given":"Philip","family":"Jones","sequence":"additional","affiliation":[{"name":"5Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-700X","authenticated-orcid":true,"given":"Casey R.","family":"Ager","sequence":"additional","affiliation":[{"name":"6Department of Immunology, The Mayo Clinic, Scottsdale, Arizona."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4996-7207","authenticated-orcid":true,"given":"Michael A.","family":"Curran","sequence":"additional","affiliation":[{"name":"1Immunology Program, The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas."},{"name":"2Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"2024032514002325500_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"2024032514002325500_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"2024032514002325500_bib3","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1073\/pnas.0900850106","article-title":"ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization","volume":"106","author":"Sun","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032514002325500_bib4","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci Signal"},{"key":"2024032514002325500_bib5","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.4049\/jimmunol.1401869","article-title":"STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells","volume":"193","author":"Klarquist","year":"2014","journal-title":"J Immunol"},{"key":"2024032514002325500_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"2024032514002325500_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","article-title":"Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis","volume":"14","author":"Xia","year":"2016","journal-title":"Cell Rep"},{"key":"2024032514002325500_bib8","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","article-title":"Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis","volume":"76","author":"Xia","year":"2016","journal-title":"Cancer Res"},{"key":"2024032514002325500_bib9","first-page":"34","article-title":"Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer","volume":"9","author":"Barbie","year":"2018","journal-title":"Cancer Discovery"},{"key":"2024032514002325500_bib10","doi-asserted-by":"crossref","first-page":"e77846","DOI":"10.1371\/journal.pone.0077846","article-title":"Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides","volume":"8","author":"Yi","year":"2013","journal-title":"PLoS One"},{"key":"2024032514002325500_bib11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4049\/jimmunol.1300798","article-title":"An alternative splicing isoform of MITA antagonizes MITA-mediated induction of type I IFNs","volume":"192","author":"Chen","year":"2014","journal-title":"J Immunol"},{"key":"2024032514002325500_bib12","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1093\/nar\/gky186","article-title":"A novel transcript isoform of STING that sequesters cGAMP and dominantly inhibits innate nucleic acid sensing","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2024032514002325500_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.immuni.2009.01.008","article-title":"The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA","volume":"30","author":"Zhong","year":"2009","journal-title":"Immunity"},{"key":"2024032514002325500_bib14","doi-asserted-by":"crossref","first-page":"11932","DOI":"10.1038\/ncomms11932","article-title":"Activation of STING requires palmitoylation at the Golgi","volume":"7","author":"Mukai","year":"2016","journal-title":"Nat Commun"},{"key":"2024032514002325500_bib15","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.celrep.2016.05.023","article-title":"STING pathway activation stimulates potent immunity against acute myeloid leukemia","volume":"15","author":"Curran","year":"2016","journal-title":"Cell Rep"},{"key":"2024032514002325500_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2032-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat Chem Biol"},{"key":"2024032514002325500_bib17","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.1423804112","article-title":"Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease","volume":"112","author":"Grieves","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032514002325500_bib18","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1038\/s41598-017-12308-4","article-title":"Double deficiency of Trex2 and DNase1L2 nucleases leads to accumulation of DNA in lingual cornifying keratinocytes without activating inflammatory responses","volume":"7","author":"Manils","year":"2017","journal-title":"Sci Rep"},{"key":"2024032514002325500_bib19","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"2024032514002325500_bib20","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1158\/0008-5472.CAN-08-3289","article-title":"Tumor vaccines expressing Flt3 ligand synergize with CTLA-4 blockade to reject preimplanted tumors","volume":"69","author":"Curran","year":"2009","journal-title":"Cancer Res"},{"key":"2024032514002325500_bib21","doi-asserted-by":"crossref","first-page":"126640","DOI":"10.1016\/j.bmcl.2019.126640","article-title":"Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy","volume":"29","author":"Ager","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"2024032514002325500_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nri3682","article-title":"Post-transcriptional regulation of gene expression in innate immunity","volume":"14","author":"Carpenter","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2024032514002325500_bib23","doi-asserted-by":"crossref","first-page":"e003246","DOI":"10.1136\/jitc-2021-003246","article-title":"High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege","volume":"9","author":"Ager","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2024032514002325500_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fonc.2015.00083","article-title":"Targeting the innate immune system as immunotherapy for acute myeloid leukemia","volume":"5","author":"Curran","year":"2015","journal-title":"Front Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0095\/3422918\/crc-24-0095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/3\/911\/3432484\/crc-24-0095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/3\/911\/3432484\/crc-24-0095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T10:00:54Z","timestamp":1711360854000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/3\/911\/741934\/Identification-of-Nonfunctional-Alternatively"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,25]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0095","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25471944.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471938.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471950.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471941.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471956","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471947","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471938","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471956.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471950","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471953","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471941","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471944","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471947.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25471953.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7148454","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7148454.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]}}}